Schepart A - Search Results

1

Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.

Bourque JM, Schepart A, Bhambri R, Castaño A, O'Brien A, Chen Y, Prasad S, Roy A, Grodin JL. Bourque JM, et al. Among authors: schepart a. Am J Cardiol. 2022 Mar 15;167:98-103. doi: 10.1016/j.amjcard.2021.11.048. Epub 2022 Jan 10. Am J Cardiol. 2022. PMID: 35022130 Free article.

2

Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.

Willis C, Watanabe AH, Hughes J, Nolen K, O'Meara J, Schepart A, Bruno M, Biskupiak J, Kawamoto K, Shara N, Kannampallil T. Willis C, et al. Among authors: schepart a. Future Cardiol. 2022 May;18(5):367-376. doi: 10.2217/fca-2021-0122. Epub 2022 Jan 31. Future Cardiol. 2022. PMID: 35098741

3

Assessment of algorithms for identifying patients with triple-class refractory multiple myeloma using real-world data.

Sinyavskaya L, Meche A, Faucher A, Hlavacek P, Johnson SMA, DiBonaventura M, Vekeman F, Ren J, Schepart A. Sinyavskaya L, et al. Among authors: schepart a. Curr Med Res Opin. 2024 May;40(5):789-801. doi: 10.1080/03007995.2024.2333439. Epub 2024 Apr 12. Curr Med Res Opin. 2024. PMID: 38523576

4

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.

Costa LJ, LeBlanc TW, Tesch H, Sonneveld P, Kyle RP, Sinyavskaya L, Hlavacek P, Meche A, Ren J, Schepart A, Aydin D, Nador G, DiBonaventura MD. Costa LJ, et al. Among authors: schepart a. Future Oncol. 2024;20(17):1175-1189. doi: 10.2217/fon-2023-0995. Epub 2024 Feb 28. Future Oncol. 2024. PMID: 38415370 Free PMC article.

5

A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma.

Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Schepart A, Hlavacek P. Mol I, et al. Among authors: schepart a. Leuk Lymphoma. 2024 May;65(5):660-668. doi: 10.1080/10428194.2024.2313628. Epub 2024 Feb 12. Leuk Lymphoma. 2024. PMID: 38347747

6

A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma.

Mol I, Hu Y, LeBlanc TW, Cappelleri JC, Chu H, Nador G, Aydin D, Schepart A, Hlavacek P. Mol I, et al. Among authors: schepart a. Curr Med Res Opin. 2024 Feb;40(2):199-207. doi: 10.1080/03007995.2023.2277850. Epub 2024 Jan 24. Curr Med Res Opin. 2024. PMID: 38078866

7

Artificial intelligence-enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges.

Schepart A, Burton A, Durkin L, Fuller A, Charap E, Bhambri R, Ahmad FS. Schepart A, et al. Cardiovasc Digit Health J. 2023 May 3;4(3):101-110. doi: 10.1016/j.cvdhj.2023.04.003. eCollection 2023 Jun. Cardiovasc Digit Health J. 2023. PMID: 37351333 Free PMC article.

8

Medicare characteristics, treatment, cost and survival in triple class exposed relapsed or refractory multiple myeloma.

Hlavacek P, Schepart A, Silverstein AR, Petrilla AA, Johnson W, Schroeder A. Hlavacek P, et al. Among authors: schepart a. Future Oncol. 2023 Apr;19(11):775-787. doi: 10.2217/fon-2022-1018. Epub 2023 May 3. Future Oncol. 2023. PMID: 37132520

9

Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model.

Bruno M, Sheer R, Reed C, Schepart A, Nair R, Simmons JD. Bruno M, et al. Among authors: schepart a. J Manag Care Spec Pharm. 2023 May;29(5):530-540. doi: 10.18553/jmcp.2023.29.5.530. J Manag Care Spec Pharm. 2023. PMID: 37121249 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters